华海药业 (600521.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(华海药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2024年一季报2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 5,128,307,063.042,498,671,124.158,308,719,758.466,207,564,556.194,294,130,016.332,058,913,113.438,265,744,793.285,837,951,184.613,823,472,246.001,772,607,601.98
 营业利润(元) 957,481,742.99374,627,295.801,124,539,623.55924,334,295.14694,035,279.19243,583,809.251,547,171,357.531,030,338,323.34700,687,436.47200,764,620.47
 利润总额(元) 956,425,345.50371,845,376.741,100,321,379.94907,967,309.17685,463,564.28240,883,645.681,508,899,776.161,023,613,099.31695,019,365.04197,928,828.23
 净利润(元) 754,349,946.71273,944,434.55817,249,345.21713,177,829.99562,809,707.68168,505,392.261,176,009,472.86804,387,508.78576,303,328.05139,878,030.56
 归属于母公司股东的净利润(元) 748,566,030.81270,842,789.22830,466,003.18721,556,692.14568,819,789.73172,934,924.851,167,758,749.48794,518,892.99567,996,952.57137,701,672.91
盈利能力:
 销售毛利率(%) 62.0159.7460.4258.9660.1358.8762.3661.3961.9961.64
 销售净利率(%) 14.7110.969.8411.4913.118.1814.2313.7815.077.89
 净资产收益率(%) 8.773.3710.639.517.402.40----
 总资产报酬率ROA(%) 5.082.136.735.523.851.90----
 投入资本回报率ROIC(%) 4.741.675.504.783.641.148.596.014.411.08
营运能力:
 存货周转率(次) 0.580.310.970.750.520.27----
 应收账款周转率(次) 1.810.993.232.491.750.93----
 总资产周转率(次) 0.260.130.450.350.240.12----
偿债能力:
 资产负债率(%) 54.0657.7455.6455.2156.7557.5857.3356.5254.6756.55
 股东权益比率(%) 45.1141.4143.4243.8242.3241.3741.5742.0543.9342.07
 已获利息倍数(倍) 28.129.919.0214.45347.023.74-138.29-7.11-20.794.58
 流动比率 1.421.331.401.631.581.651.651.671.871.81
 速动比率 0.830.830.750.850.940.950.920.880.991.01
发展能力:
 营业收入增长率(%) 19.4321.360.526.3312.3116.1524.4226.9825.9718.42
 营业利润增长率(%) 37.9653.80-27.32-10.29-0.9521.3378.1631.667.12-40.22
 税后利润增长率(%) 31.6056.62-28.88-9.180.1425.59139.5234.7510.15-46.02
 净资产增长率(%) 6.397.567.0313.7116.4715.4815.064.485.20-0.95
 总资产增长率(%) -0.197.462.479.1220.8917.4217.3514.3811.3922.98

前瞻产业研究院